SLB
55
2
HAS
33
3
DE
63
3
M
37
12
LYB
39
2
FDX
43
3
NRG
49
-3
TGT
22
2
URBN
56
14
LRCX
43
-2
MCHP
41
4
SYY
53
4
STZ
54
-3
MET
72
5
NVDA
56
-4
GIS
31
3
PYPL
54
2
PSA
58
2
AIV
72
2
ORLY
62
2
SLB
55
2
HAS
33
3
DE
63
3
M
37
12
LYB
39
2
FDX
43
3
NRG
49
-3
TGT
22
2
URBN
56
14
LRCX
43
-2
MCHP
41
4
SYY
53
4
STZ
54
-3
MET
72
5
NVDA
56
-4
GIS
31
3
PYPL
54
2
PSA
58
2
AIV
72
2
ORLY
62
2
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
47

BIO
Bio-Rad Laboratories

Last Price:
332.86
Seasonality Move:
7.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $99.97M
Price / Cash Flow: 42.29
Annual Sales: $267.46
Price / Book: 1.24

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.69M
Gross Margin: $1.43B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 29.02

BIO Technical Analysis vs Fundamental Analysis

Sell
47
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?